Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.4K Sell
76,053
-268,553
-78% -$251K ﹤0.01% 3299
2025
Q4
$534K Sell
344,606
-44,465
-11% -$71K 0.01% 1529
2025
Q3
$615K Buy
389,071
+214,405
+123% +$373K 0.03% 918
2025
Q2
$381K Buy
+174,666
New +$423K 0.02% 1285
2025
Q1
Sell
-58,866
Closed -$245K 2839
2024
Q4
$245K Buy
+58,866
New +$222K 0.02% 1386

Other funds holding MXCT

XTX Topco's MXCT Position: Q1 2026 in Review

XTX Topco reduced its MaxCyte (MXCT) stake by 78% in Q1 2026, selling an estimated $251K and leaving 76,053 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3299.

XTX Topco first reported a position in MXCT in Q4 2024 and has held it in 5 quarters since. The position peaked at $615K in Q3 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • XTX Topco held 76,053 shares of MaxCyte worth $53.4K as of Q1 2026.
  • XTX Topco sold 268,553 MaxCyte shares in Q1 2026, an estimated $251K.
  • MaxCyte made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3299 holding.
  • XTX Topco first reported a position in MaxCyte in Q4 2024 and has held it in 5 quarters since.
  • XTX Topco's MaxCyte position peaked at $615K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.